We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 81-100 of 492 results
  1. Early antipsychotic exposure affects serotonin and dopamine receptor binding density differently in selected brain loci of male and female juvenile rats

    Background

    Antipsychotic drugs (APDs) were developed to treat schizophrenia in adults; however they have been increasingly prescribed (mostly...

    Jiamei Lian, Bo Pan, Chao Deng in Pharmacological Reports
    Article 17 July 2016
  2. An immune gate of depression — Early neuroimmune development in the formation of the underlying depressive disorder

    The prevalence of depression worldwide is increasing from year to year and constitutes a serious medical, economic and social problem. Currently,...

    Małgorzata Kowalczyk, Janusz Szemraj, ... Piotr Gałecki in Pharmacological Reports
    Article 28 May 2019
  3. Clobenpropit, a histamine H3 receptor antagonist/inverse agonist, inhibits [3H]-dopamine uptake by human neuroblastoma SH-SY5Y cells and rat brain synaptosomes

    Background

    Clobenpropit, a potent antagonist/inverse agonist at the histamine H 3 receptor (H 3 R), reduced the cytotoxic action of 6-hydroxydopamine...

    Elvia Mena-Avila, Ricardo Márquez-Gómez, ... José-Antonio Arias-Montaño in Pharmacological Reports
    Article 30 August 2017
  4. Effects of central RVD-hemopressin(α) administration on anxiety, feeding behavior and hypothalamic neuromodulators in the rat

    Background

    The endocannabinoid (eCB) system is strongly involved in the regulation of anxiety and feeding behavior. RVD-hemopressin(α) [RVD-hp(α)], a...

    Lucia Recinella, Annalisa Chiavaroli, ... Sheila Leone in Pharmacological Reports
    Article 02 February 2018
  5. Regularly monitor neuropsychiatric symptoms in Parkinson’s disease and adjust treatment as necessary

    Neuropsychiatric disorders are frequent in Parkinson’s disease (PD), but may be difficult to identify as they are closely related to other aspects of...

    Article 03 January 2019
  6. Recent and updated pharmacotherapy of migraine

    Migraine is a complex and still debatable neurovascular disorder that is on the rise globally, affecting patients of all ages. Various drugs are...

    Alok Singh, Pugazhenthan Thangaraju, Suryaprakash Dhaneria in Drugs & Therapy Perspectives
    Article 08 August 2019
  7. Glutamate heteroreceptor complexes in the brain

    The existence of mGluR, NMDAR, AMPAR and putative KAR heteroreceptor complexes in synaptic and extrasynaptic regions of brain glutamate synapses...

    Dasiel O. Borroto-Escuela, Alexander O. Tarakanov, ... Kjell Fuxe in Pharmacological Reports
    Article 11 April 2018
  8. BIOLOGICAL ACTIVITY OF COMPOUNDS OF PLANT ORIGIN

    Due to their structural diversity and specific biological effects, natural substances play an important role in medication. Many of the medicines...
    Éva Szöke, Ágnes Kéry, Éva Lemberkovics in From Herbs to Healing
    Chapter 2023
  9. Isobolographic analysis of the cutaneous antinociceptive interaction between bupivacaine co-injected with serotonin in rats

    Background

    The aim of this experiment was to investigate a long-lasting local anesthetic bupivacaine combined with serotonin at inducing cutaneous...

    Jann-Inn Tzeng, Chong-Chi Chiu, ... Ching-Hsia Hung in Pharmacological Reports
    Article 29 March 2017
  10. Abnormal hippocampal neurogenesis in Parkinson’s disease: relevance to a new therapeutic target for depression with Parkinson’s disease

    Parkinson’s disease (PD) is a common progressive neurodegenerative disorder characterized by motor dysfunction, including bradykinesia, tremor,...

    Juhee Lim, Yeo** Bang, Hyun ** Choi in Archives of Pharmacal Research
    Article 22 August 2018
  11. Combined treatment with aripiprazole and antidepressants reversed some MK-801-induced schizophrenia-like symptoms in mice

    Background

    Atypical antipsychotic drugs have some efficacy in alleviating the negative and some cognitive symptoms of schizophrenia but those effects...

    Zofia Rogóż, Agnieszka Wąsik, Elzbieta Lorenc-Koci in Pharmacological Reports
    Article 24 February 2018
  12. Involvement of vascular endothelial growth factor (VEGF) and mitogen-activated protein kinases (MAPK) in the mechanism of neuroleptic drugs

    Background

    Recent evidence suggests that the mitogen activated protein kinase (MAPK)-associated signaling pathway in the frontal cortical areas...

    Marta Jóźwiak-Bębenista, Magdalena Jasińska-Stroschein, Edward Kowalczyk in Pharmacological Reports
    Article 23 August 2018
  13. The role of nitric oxide—cGMP pathway in selegiline antidepressant-like effect in the mice forced swim test

    Background

    Considering the pivotal role of nitric oxide (NO) pathway in depressive disorders, the aim of the present study was to investigate the...

    Sattar Ostadhadi, Saeed Shakiba, ... Ahmad-Reza Dehpour in Pharmacological Reports
    Article 13 May 2018
  14. Depressive-like neurochemical and behavioral markers of Parkinson’s disease after 6-OHDA administered unilaterally to the rat medial forebrain bundle

    Background

    Although Parkinson’s disease (PD) is characterized by progressive neurodegeneration of multiple neurotransmitter systems, 6-hydroxydopamine...

    Kinga Kamińska, Tomasz Lenda, ... Elżbieta Lorenc-Koci in Pharmacological Reports
    Article 03 June 2017
  15. The influence of CaMKII and ERK phosphorylation on BDNF changes observed in mice selectively devoid of CREB in serotonergic or noradrenergic neurons

    Background

    The transcription factor CREB and the neurotrophin BDNF are important mood regulators due to their profound role in controlling the...

    Katarzyna Rafa-Zabłocka, Grzegorz Kreiner, ... Irena Nalepa in Pharmacological Reports
    Article 09 April 2019
  16. Bupropion attenuates morphine tolerance and dependence: Possible role of glutamate, norepinephrine, inflammation, and oxidative stress

    Background

    Morphine — the main pillar of nociceptive pain management — systemic use is associated with development of tolerance and dependence....

    Mostafa Mahmoud Hamdy, Mohamed Mostafa Elbadr, Ahmed Barakat in Pharmacological Reports
    Article 11 April 2018
  17. Emotional disorders induced by Hemopressin and RVD-hemopressin(α) administration in rats

    Background

    The endocannabinoid (eCB) system plays an important role in regulating emotional disorders, and is involved, directly or indirectly, in...

    Sheila Leone, Lucia Recinella, ... Giustino Orlando in Pharmacological Reports
    Article 23 June 2017
  18. Skin nociceptive block with pramoxine delivery by subcutaneous injection in rats

    Background

    Pramoxine has been shown to produce spinal anesthesia, while cutaneous analgesia (peripheral) of pramoxine is not established. The...

    An-Kuo Chou, Chong-Chi Chiu, ... Ching-Hsia Hung in Pharmacological Reports
    Article 10 September 2018
  19. The effect of paroxetine, venlafaxine and bupropion administration alone and combined on spatial and aversive memory performance in rats

    Background

    The use of antidepressants in combination is common practice following non-response to single antidepressant agents. Nevertheless, the...

    Carlos Eduardo de Souza Menezes, Roger S. McIntyre, ... Danielle Macêdo in Pharmacological Reports
    Article 21 July 2018
Did you find what you were looking for? Share feedback.